DK3216802T3 - Produktionsfremgangsmåde - Google Patents
Produktionsfremgangsmåde Download PDFInfo
- Publication number
- DK3216802T3 DK3216802T3 DK17159323.9T DK17159323T DK3216802T3 DK 3216802 T3 DK3216802 T3 DK 3216802T3 DK 17159323 T DK17159323 T DK 17159323T DK 3216802 T3 DK3216802 T3 DK 3216802T3
- Authority
- DK
- Denmark
- Prior art keywords
- production procedure
- procedure
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95677207P | 2007-08-20 | 2007-08-20 | |
| EP20120171016 EP2527367A1 (en) | 2007-08-20 | 2008-08-19 | Production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3216802T3 true DK3216802T3 (da) | 2021-01-04 |
Family
ID=40070558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17159323.9T DK3216802T3 (da) | 2007-08-20 | 2008-08-19 | Produktionsfremgangsmåde |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9163249B2 (da) |
| EP (3) | EP2527367A1 (da) |
| JP (2) | JP5592258B2 (da) |
| KR (1) | KR101637533B1 (da) |
| CN (1) | CN101848936B (da) |
| AU (1) | AU2008290607B2 (da) |
| BR (1) | BRPI0815576A2 (da) |
| CA (1) | CA2695484C (da) |
| DK (1) | DK3216802T3 (da) |
| EA (1) | EA022990B1 (da) |
| ES (2) | ES2840725T3 (da) |
| MX (1) | MX2010002003A (da) |
| WO (1) | WO2009024567A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2695484C (en) * | 2007-08-20 | 2018-05-01 | Glaxo Group Limited | Production method of therapeutic proteins based on codon adaptation |
| WO2010102982A1 (en) * | 2009-03-10 | 2010-09-16 | Dsm Ip Assets B.V. | Method for improving the yield of a polypeptide |
| WO2011084145A2 (en) * | 2009-12-21 | 2011-07-14 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
| JP6039552B2 (ja) | 2010-07-01 | 2016-12-07 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 高産生細胞株を選択するための改良された方法 |
| GB201112429D0 (en) | 2011-07-19 | 2011-08-31 | Glaxo Group Ltd | Antigen-binding proteins with increased FcRn binding |
| RU2015130100A (ru) | 2013-01-24 | 2017-03-03 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | TNF-альфа антиген-связывающие белки |
| MX2018005084A (es) * | 2015-11-05 | 2019-05-16 | Bamboo Therapeutics Inc | Genes de ataxia de friedreich modificados y vectores para terapia genica. |
| WO2017162265A1 (en) | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Trans-replicating rna |
| WO2017162266A1 (en) | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Rna replicon for versatile and efficient gene expression |
| AU2018333503A1 (en) | 2017-09-13 | 2020-02-27 | BioNTech SE | RNA replicon for reprogramming somatic cells |
| WO2019053056A1 (en) | 2017-09-13 | 2019-03-21 | Biontech Cell & Gene Therapies Gmbh | RNA REPLICON FOR EXPRESSING A T CELL RECEPTOR OR ARTIFICIAL LYMPHOCYTIC T CELL RECEPTOR |
| EP4162034A1 (en) | 2020-06-04 | 2023-04-12 | BioNTech SE | Rna replicon for versatile and efficient gene expression |
| WO2023066875A1 (en) | 2021-10-18 | 2023-04-27 | BioNTech SE | Modified replicable rna and related compositions and their use |
| CA3234214A1 (en) | 2021-10-18 | 2023-04-27 | BioNTech SE | Methods for determining mutations for increasing modified replicable rna function and related compositions and their use |
| WO2023213378A1 (en) | 2022-05-02 | 2023-11-09 | BioNTech SE | Replicon compositions and methods of using same for the treatment of diseases |
| WO2024017479A1 (en) | 2022-07-21 | 2024-01-25 | BioNTech SE | Multifunctional cells transiently expressing an immune receptor and one or more cytokines, their use and methods for their production |
| WO2024056856A1 (en) | 2022-09-15 | 2024-03-21 | BioNTech SE | Systems and compositions comprising trans-amplifying rna vectors with mirna |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953639A1 (en) * | 1998-04-30 | 1999-11-03 | Boehringer Ingelheim International GmbH | FAPalpha-specific antibody with improved producibility |
| EP1373547A4 (en) | 2001-03-27 | 2006-01-18 | Smithkline Beecham Corp | CONTROL OF GLYCOFORMS IN IGG |
| CA2501945A1 (en) | 2002-10-09 | 2004-04-22 | Rinat Neuroscience Corp. | Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| AU2003294297A1 (en) | 2002-11-15 | 2004-06-15 | The Henry M. Jackson Foundation | Recombinant hiv-1 subclass d envelope glycoproteins |
| US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
| CA2565907A1 (en) * | 2004-05-17 | 2005-11-24 | Crucell Holland B.V. | Methods for diagnosis of acute myeloid leukemia |
| US7462697B2 (en) * | 2004-11-08 | 2008-12-09 | Epitomics, Inc. | Methods for antibody engineering |
| TW200635607A (en) * | 2004-12-15 | 2006-10-16 | Elan Pharm Inc | Humanized Aβ antibodies for use in improving cognition |
| WO2006081171A1 (en) * | 2005-01-24 | 2006-08-03 | Amgen Inc. | Humanized anti-amyloid antibody |
| KR101273829B1 (ko) * | 2005-05-20 | 2013-06-11 | 론자 바이올로직스 피엘씨 | 포유류 숙주 세포에서의 재조합 항체의 고-수준 발현 |
| RS52004B (en) | 2005-12-12 | 2012-04-30 | F. Hoffmann-La Roche Ag | ANTIBODIES AGAINST AMYLOID BETA WITH GLYCOSILATION IN THE VARIABLE REGION |
| EP2177536B1 (en) * | 2006-03-30 | 2014-06-04 | Glaxo Group Limited | Antibodies against amyloid-beta peptide |
| CA2646048A1 (en) * | 2006-03-30 | 2007-11-08 | Novartis Ag | Compositions and methods of use for antibodies of c-met |
| CA2695484C (en) * | 2007-08-20 | 2018-05-01 | Glaxo Group Limited | Production method of therapeutic proteins based on codon adaptation |
-
2008
- 2008-08-19 CA CA2695484A patent/CA2695484C/en not_active Expired - Fee Related
- 2008-08-19 EP EP20120171016 patent/EP2527367A1/en not_active Withdrawn
- 2008-08-19 US US12/674,069 patent/US9163249B2/en active Active
- 2008-08-19 JP JP2010521409A patent/JP5592258B2/ja active Active
- 2008-08-19 EA EA201000205A patent/EA022990B1/ru not_active IP Right Cessation
- 2008-08-19 BR BRPI0815576 patent/BRPI0815576A2/pt not_active Application Discontinuation
- 2008-08-19 AU AU2008290607A patent/AU2008290607B2/en not_active Ceased
- 2008-08-19 ES ES17159323T patent/ES2840725T3/es active Active
- 2008-08-19 WO PCT/EP2008/060834 patent/WO2009024567A1/en active Application Filing
- 2008-08-19 CN CN200880111547.1A patent/CN101848936B/zh active Active
- 2008-08-19 MX MX2010002003A patent/MX2010002003A/es not_active Application Discontinuation
- 2008-08-19 KR KR1020107006104A patent/KR101637533B1/ko active IP Right Grant
- 2008-08-19 ES ES08787316.2T patent/ES2473623T3/es active Active
- 2008-08-19 DK DK17159323.9T patent/DK3216802T3/da active
- 2008-08-19 EP EP17159323.9A patent/EP3216802B1/en active Active
- 2008-08-19 EP EP20080787316 patent/EP2185591B1/en active Active
-
2014
- 2014-07-31 JP JP2014155890A patent/JP6029625B2/ja active Active
-
2015
- 2015-09-30 US US14/870,065 patent/US10633673B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3216802B1 (en) | 2020-10-07 |
| US9163249B2 (en) | 2015-10-20 |
| KR20100065332A (ko) | 2010-06-16 |
| WO2009024567A1 (en) | 2009-02-26 |
| EA022990B1 (ru) | 2016-04-29 |
| KR101637533B1 (ko) | 2016-07-11 |
| AU2008290607B2 (en) | 2013-11-14 |
| JP2015027298A (ja) | 2015-02-12 |
| CA2695484A1 (en) | 2009-02-26 |
| EP3216802A1 (en) | 2017-09-13 |
| EP2185591B1 (en) | 2014-05-14 |
| CA2695484C (en) | 2018-05-01 |
| AU2008290607A1 (en) | 2009-02-26 |
| JP6029625B2 (ja) | 2016-11-24 |
| JP5592258B2 (ja) | 2014-09-17 |
| BRPI0815576A2 (pt) | 2015-02-18 |
| ES2473623T3 (es) | 2014-07-07 |
| ES2840725T3 (es) | 2021-07-07 |
| US20110040074A1 (en) | 2011-02-17 |
| CN101848936B (zh) | 2017-05-03 |
| EP2527367A1 (en) | 2012-11-28 |
| EP2185591A1 (en) | 2010-05-19 |
| EA201000205A1 (ru) | 2011-02-28 |
| US20160010111A1 (en) | 2016-01-14 |
| MX2010002003A (es) | 2010-03-10 |
| US10633673B2 (en) | 2020-04-28 |
| CN101848936A (zh) | 2010-09-29 |
| JP2010536358A (ja) | 2010-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3216802T3 (da) | Produktionsfremgangsmåde | |
| BRPI0821573A2 (pt) | benzofuropirimidonas | |
| ATE501136T1 (de) | Imidazopyridinone | |
| ATE514696T1 (de) | Diphenyl-dihydro-imidazopyridinone | |
| DE112008003636A5 (de) | Mehrzuggruppierer | |
| DE502007001207D1 (de) | Elektrosaugkopf | |
| BRPI0814519A2 (pt) | Organopolissiloxano | |
| BRPI0811451A2 (pt) | Exopolissacarídeo | |
| DE602008000749D1 (de) | Buschschneider | |
| DE602008000923D1 (de) | Einzelwaferätzgerät | |
| BRPI0812840A2 (pt) | 2-imidazolinas | |
| FI20075851A0 (fi) | Muodostusosa | |
| BRPI0815547A2 (pt) | Depsipeptídeos cícliocos | |
| AT505058A3 (de) | Türschliesssystem | |
| BRPI0809678A2 (pt) | Métodos | |
| BRPI0812994A2 (pt) | Microbiocidas | |
| DE112008001216A5 (de) | Magnetronplasmaanlage | |
| DE502008001694D1 (de) | Mitfahrhubwagen | |
| DE112008003094A5 (de) | Geomatte | |
| DE502008003063D1 (de) | Magnetventilinjektor | |
| DE112008003196A5 (de) | Handpipettiergerät | |
| BRPI0815419A2 (pt) | Método de produção | |
| DE112008002200A5 (de) | Sperrsynchronisiervorrichtung | |
| DE602008000292D1 (de) | Werkzeughaltepositioniervorrichtung | |
| CU20090155A7 (es) | Macrolidos |